Doxylamine
Antihistamine — RESPIRATORY SYSTEM
Also known as: (+/-)-Doxylamine, doxylamine succinate
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Doxylamine is an ofp drug in the Antihistamine class catalogued in DrugCentral. It was first approved by the FDA in 1948. Its mechanism of action is classified as Histamine Receptor Antagonists. DrugCentral lists 1 molecular target, including HRH1. Recorded indications include Allergic conjunctivitis, Allergic rhinitis, Common cold and Dermatographic urticaria.
- Approval status: ofp (first approved 1948 by the FDA).
- Drug class: Antihistamine.
- Mechanism of action: Histamine Receptor Antagonists.
- Molecular targets: HRH1 (1 listed in DrugCentral).
- Indications: Allergic conjunctivitis, Allergic rhinitis, Common cold, Dermatographic urticaria and Influenza-like symptoms and others.
- ATC code: R06AA09 (Aminoalkyl ethers).
- Molecular formula: C17H22N2O; molecular weight 270.38 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (12)
- Allergic conjunctivitis
- Allergic rhinitis
- Common cold
- Dermatographic urticaria
- Influenza-like symptoms
- Itching of skin
- Nasal congestion
- Nasal discharge
- Seasonal allergic rhinitis
- Sneezing
- Urticaria
- Vasomotor rhinitis
Off-label uses (1)
- Morning sickness
Contraindications (28)
- Acidosis
- Acute hepatitis
- Acute pancreatitis
- Alcoholism
- Angle-closure glaucoma
- Arterial thrombosis
- Arteriosclerotic vascular disease
- Benign prostatic hyperplasia
- Bladder outflow obstruction
- Bradycardia
- Chronic heart failure
- Chronic idiopathic constipation
- Coronary arteriosclerosis
- Diabetes mellitus
- Disease of liver
- Disorder of coronary artery
- Hepatic failure
- Hypertensive disorder
- Hypertensive urgency
- Hyperthyroidism
- Hypoxia
- Myocardial infarction
- Ocular hypertension
- Partial atrioventricular block
- Peptic ulcer
- Poisoning by acetaminophen
- Retention of urine
- Ventricular tachycardia
Mechanism & targets
| Mechanism of action (MoA) | Histamine Receptor Antagonists |
|---|---|
| Established pharmacologic class | Antihistamine |
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Histamine H1 receptor | HRH1 | antagonist | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| 1948-04-07 | FDA | — | SANOFI AVENTIS US |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
R06AA09 | RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Aminoalkyl ethers |
R06AA59 | RESPIRATORY SYSTEM › ANTIHISTAMINES FOR SYSTEMIC USE › ANTIHISTAMINES FOR SYSTEMIC USE › Aminoalkyl ethers |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Toxicity to various agents | 7958.0 |
| Completed suicide | 4902.1 |
| Exposure to toxic agent | 3116.1 |
| Intentional overdose | 2825.7 |
| Overdose | 2797.6 |
| Acute hepatic failure | 2623.2 |
| Infusion related reaction | 1704.8 |
| Blood pressure fluctuation | 1360.6 |
| Hepatic cytolysis | 1154.7 |
| Suicide attempt | 1048.5 |
| Intentional product misuse | 897.2 |
| Intentional product use issue | 871.7 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Doxylamine is on its molecule page.
| Molecular formula | C17H22N2O |
|---|---|
| Molecular weight | 270.38 g/mol |
| CAS number | 469-21-6 |
| InChIKey | HCFDWZZGGLSKEP-UHFFFAOYSA-N |
| PubChem CID | 3162 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Doxylamine used for?
DrugCentral lists the following indications for Doxylamine: Allergic conjunctivitis, Allergic rhinitis, Common cold, Dermatographic urticaria, Influenza-like symptoms, Itching of skin, Nasal congestion and Nasal discharge and others.
How does Doxylamine work?
Doxylamine is classified as Histamine Receptor Antagonists; its molecular targets in DrugCentral include HRH1 (antagonist).
When was Doxylamine first approved?
Doxylamine was first approved by the FDA in 1948.
What drug class does Doxylamine belong to?
Doxylamine is in the Antihistamine class.
What is the chemical formula of Doxylamine?
Doxylamine has the molecular formula C17H22N2O and a molecular weight of 270.38 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 962 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1004 — compound record and bioactivity
- PubChem CID 3162 — chemical identifiers
- DrugBank DB00366 — drug record
- FDA UNII 95QB77JKPL — substance identity
- DailyMed: FDA labels for Doxylamine — current prescribing information (label search)
- UniProt P35367 (HRH1) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.